ALKBH5 and intrahepatic cholangiocarcinoma: In addition, in intrahepatic cholangiocarcinoma (ICC), ALKBH5 positively regulates PD-L1 expression in tumor cells and inhibits the expansion and cytotoxicity of T cells through PD-1/PD-L1 signaling (Table 1) [89].